Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Efficacy and safety of low-dose rituximab as induction therapy for antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement: a Chinese case series

Fig. 2

Response to treatment with RTX or CYC in patients with AAV. Changes in serum creatinine (a), eGFR (b), albumin (c), 24 h urine protein (d), ANCA titer (e), HGB (f). BVAS (g) RTX vs baseline: *P < 0.05, **P < 0.01. CYC vs baseline: #P < 0.05, ##P < 0.01. CYC vs RTX: &P < 0.05, &&P < 0.01

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us